ROBBINS LARRY
Director · Ten-percent owner · BFLY, CVS
As of 2026-09-16, ROBBINS LARRY has 33 Form 4 transactions on record across 2 companies — 25 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in May in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | BFLY | Sale | 582,500 @ $8.97 | $5.2M | −16.4% of holding | 2,964,187 | Form 4 |
| 2026-08-14 | BFLY | Sale | 824,700 @ $8.70 | $7.2M | −18.9% of holding | 3,546,687 | Form 4 |
| 2026-08-13 | BFLY | Sale | 500,000 @ $9.24 | $4.6M | −4.1% of holding | 11,743,530 | Form 4 |
| 2026-08-13 | BFLY | Sale | 215,233 @ $9.54 | $2.1M | −1.7% of holding | 12,243,530 | Form 4 |
| 2026-08-13 | BFLY | Sale | 175,300 @ $8.86 | $1.6M | −3.9% of holding | 4,371,387 | Form 4 |
| 2026-08-03 | BFLY | Sale | 156,163 @ $8.10 | $1.3M | −1.2% of holding | 12,458,763 | Form 4 |
| 2026-07-31 | BFLY | Sale | 1,720,129 @ $7.39 | $12.7M | −12.0% of holding | 12,614,926 | Form 4 |
| 2026-05-21 | CVS | Sale | 378,000 @ $93.31 | $35.3M | −100.0% of holding | 0 | Form 4 |
| 2026-05-21 | CVS | Sale | 370,462 @ $93.45 | $34.6M | −7.1% of holding | 4,824,799 | Form 4 |
| 2026-05-20 | CVS | Sale | 797,628 @ $93.48 | $74.6M | −12.8% of holding | 5,415,633 | Form 4 |
| 2026-05-20 | CVS | Sale | 152,691 @ $94.81 | $14.5M | −2.8% of holding | 5,262,942 | Form 4 |
| 2026-05-20 | CVS | Sale | 66,881 @ $95.67 | $6.4M | −1.3% of holding | 5,196,061 | Form 4 |
| 2026-05-20 | CVS | Sale | 800 @ $96.28 | $77K | −0.0% of holding | 5,195,261 | Form 4 |
| 2026-05-19 | CVS | Sale | 1,983,387 @ $94.45 | $187.3M | −24.2% of holding | 6,213,412 | Form 4 |
| 2026-05-19 | CVS | Sale | 151 @ $95.18 | $14K | −0.0% of holding | 6,213,261 | Form 4 |
| 2025-12-11 | BFLY | Purchase | 21,370 @ $3.02 | $64K | +0.1% of holding | 14,335,055 | Form 4 |
| 2025-12-05 | BFLY | Purchase | 200,000 @ $3.06 | $611K | +1.4% of holding | 14,313,685 | Form 4 |
| 2025-12-04 | BFLY | Purchase | 536,893 @ $2.99 | $1.6M | +4.0% of holding | 14,113,685 | Form 4 |
| 2025-12-03 | BFLY | Purchase | 821,648 @ $2.96 | $2.4M | +6.4% of holding | 13,576,792 | Form 4 |
| 2025-11-21 | BFLY | Purchase | 800,000 @ $2.58 | $2.1M | +6.7% of holding | 12,755,144 | Form 4 |
| 2025-11-20 | BFLY | Purchase | 1,000,000 @ $2.37 | $2.4M | +9.1% of holding | 11,955,144 | Form 4 |
| 2025-11-19 | BFLY | Purchase | 1,000,000 @ $2.35 | $2.4M | +10.0% of holding | 10,955,144 | Form 4 |
| 2025-05-06 | CVS | Sale | 150,000 @ $66.67 | $10.0M | −1.8% of holding | 8,196,799 | Form 4 |
| 2025-05-05 | CVS | Sale | 1,226,933 @ $67.37 | $82.7M | −12.7% of holding | 8,443,798 | Form 4 |
| 2025-05-05 | CVS | Sale | 96,999 @ $67.99 | $6.6M | −1.1% of holding | 8,346,799 | Form 4 |
| 2025-05-02 | CVS | Sale | 1,679,736 @ $67.39 | $113.2M | −14.1% of holding | 10,267,063 | Form 4 |
| 2025-05-02 | CVS | Sale | 373,776 @ $69.66 | $26.0M | −3.7% of holding | 9,670,731 | Form 4 |
| 2025-05-02 | CVS | Sale | 222,556 @ $68.38 | $15.2M | −2.2% of holding | 10,044,507 | Form 4 |
5 award / exercise / gift records — not counted as purchases
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.